Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Limited has announced a proposed placement of up to 20,806,185 new fully paid ordinary shares, with the issue expected to take place on 22 January 2026. The capital raising signals the company’s intention to strengthen its balance sheet and support ongoing operational and growth initiatives, which may enhance its ability to invest in product development, commercialisation, and broader market penetration in the competitive medtech imaging space.
The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited, listed on the ASX under the code 4DX, operates in the medical technology sector, focusing on advanced imaging solutions for lung and respiratory diagnostics. The company develops and commercialises software-based and imaging technologies aimed at improving the analysis and monitoring of pulmonary function within the healthcare market.
Average Trading Volume: 4,635,655
Technical Sentiment Signal: Buy
Current Market Cap: A$2.3B
See more data about 4DX stock on TipRanks’ Stock Analysis page.